X

CERETEC FOR INJECTION 0.5mg/VIAL

Product Information

Registration Status: Active

SIN11825P

CERETEC FOR INJECTION 0.5mg/VIAL is approved to be sold in Singapore with effective from 2002-02-28. It is marketed by GE HEALTHCARE PTE LTD, with the registration number of SIN11825P.

This product contains Exametazime 0.5mg/vial in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS use.

This product is manufactured by GE HEALTHCARE AS (OSLO SITE) in NORWAY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...


Description

Exametazime is a diagnostic radiopharmaceutical agent commonly used for the preparation of Tc99m Exametazime injection. It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex. It is used in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes.

Active Ingredient/Synonyms

Exametazime | Exametazime |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!